The ESH 4th How to Diagnose and Treat Multiple Myeloma conference aims to present and debate the latest data and information in the field of multiple myeloma. This thought-provoking academic dialogue will address the most challenging current biology, clinical and therapeutic questions. The unique format of the programme, including case-based presentations, debates and round tables provides a unique platform for discussion. The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field. Chairs: Hermann Einsele (Würzburg), Irene Ghobrial (Boston), Maria-Victoria Mateos (Salamanca)

Date: Friday 14 - Sunday 16 April 2023
Venue: Vienna House Andels' Berlin, Germany

ESH How to Diagnose and Treat conferences are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction. Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Haematology CME system.

Posters and Brief Oral Communications:

Registered participants are invited to submit their clinical cases and abstracts. Selected clinical cases and abstracts will be presented as brief oral communications or posters.

Call for abstracts: deadline 29 January 2023

This meeting will be valuable to you if you are looking for:

  • A cutting-edge scientific program – from basic science to clinical and therapeutic applications and perspectives
  • Multiple opportunities for scientific interaction with an international faculty of distinguished experts
  • An emphasis on critical discussion The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in-training Learning


Upon completion of this CME activity, participants include:

  • Update on the diagnosis and profiling of myeloma
  • Upfront treatment of transplant eligible and non-eligible myeloma patients
  • Treatment of relapsed myeloma patients
  • Risk-adapted therapy
  • Immune therapy
  • Diagnosis and treatment of plasma cell dyscrasias other than multiple myeloma Scientific


  • How I treat smoldering myeloma
  • How I treat newly diagnosed multiple myeloma
  • From risk stratification to risk-based therapy?
  • Should we use MRD testing to determine therapy in multiple myeloma?
  • Is there a future role of autologous stem cell transplantation?
  • How I treat relapsed multiple myeloma
  • The FDA/EMEA and Foundations perspective on multiple myeloma
  • Should every patient receive daratumumab in first line?
  • You can’t be immune for immune therapy anymore
  • Other plasma cell dyscrasias
  • The future of multiple myeloma

The programme will include:

  • Plenary Sessions
  • Interactive Case Presentations
  • Roundtables
  • Panel Discussions
  • Debates
  • Poster Walks
  • Meet the Expert Sessions
  • Voting technology

Conference website and registration

External Events

Jan 24
Feb 24
Mar 24
Apr 24
Oct 24
January 16th 2024
CAR-T Educational Sessions for BSBMTCT-ACT Trai...
This is an online teaching session on CAR-T therapy for haematology registrars as a part of the regular educational p...
January 23rd 2024
Post ASH Significant Highlights (3)
This meeting will provide an overview of the most innovative scientific and clinical data presented at ASH 2023 that...
January 24th 2024
BSHT Annual Scientific Meeting (1)
Join scientists, clinicians, researchers, laboratory staff and all those interested in learning more about thrombosis...
January 31st 2024
Post ASH Highlights for Scotland - What's New i...
This meeting will provide an overview of the most innovative scientific and clinical data presented at ASH 2023 that...
February 6th 2024
Post ISTH & ASH Headlines 2024
This national non-malignant haematology evidence update meeting will include sessions covering relevant topics in thr...
February 7th 2024
UK Haemato-Oncology Clinical Studies Group Tria...
UK Haemato-Oncology Clinical Studies Group Trials Update meeting suitable for anyone working in this field.
February 17th 2024
FRCPath 1 Haematology Revision Course (3)
This is a popular two-day intensive exam-oriented course targeted towards haematology trainees aiming to sit their FR...
March 1st 2024
FRCPath Haemostasis and Thrombosis Training and...
The course is suitable for SpRs preparing for the part 2 FRCPath examination but is also suitable for clinicians, sci...
March 8th 2024
ESH 3rd Translational Research Conference: Chro...
ESH Translational Research Conferences propose programmes of leading-edge basic and clinical science, as well as oppo...
March 23rd 2024
Spring 2024 UCLH FRCPath Part 2 Revision Course
Intensive two-day course held at UCLH on a Saturday and Sunday to prepare candidates about to sit the Part 2 FRCPath...
April 12th 2024
ESH 9th Translational Research Conference: Myel...
TheESH 9th Ttranslational Research Conference on MDS proposes a programme of leading-edge basic and clinical science,...
April 22nd 2024
BGS Transfusion
BGS Transfusion is a three-day symposium aimed at all levels of staff working in blood transfusion.
October 28th 2024
3rd European Congress on Hematology and Blood D...
Hematology beyond blood: A holistic approach